Cargando…
Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy
BACKGROUND: Drug resistance is a major problem to control Plasmodium falciparum infection in endemic countries. During last decade, African countries have changed first-line treatment to artemisinin-based combinations therapy (ACT); sulphadoxine-pyrimethamine (SP) is recommended for Intermittent Pre...
Autores principales: | Amor, Aranzazu, Toro, Carlos, Fernández-Martínez, Amalia, Baquero, Margarita, Benito, Agustín, Berzosa, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380721/ https://www.ncbi.nlm.nih.gov/pubmed/22462737 http://dx.doi.org/10.1186/1475-2875-11-100 |
Ejemplares similares
-
Characterization of the Plasmodium falciparum Sarcoplasmic/Endoplasmic Reticulum Ca(2+)-ATPase Gene in Samples from Equatorial Guinea before Implementation of Artemisinin-Based Combination Therapy
por: Fernández-Martínez, Amalia, et al.
Publicado: (2013) -
Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia
por: Mula, Patricia, et al.
Publicado: (2011) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
por: Duffey, Maëlle, et al.
Publicado: (2018) -
Screening for K13-Propeller Mutations Associated with Artemisinin Resistance in Plasmodium falciparum in Yambio County (Western Equatoria State, South Sudan)
por: Molina-de la Fuente, Irene, et al.
Publicado: (2023) -
Plasmodium falciparum: multifaceted resistance to artemisinins
por: Paloque, Lucie, et al.
Publicado: (2016)